User profiles for M. Scarpa

Marco Scarpa

General Surgery Unit, University Hospital of Padova, Padova, Italy
Verified email at aopd.veneto.it
Cited by 7975

[HTML][HTML] Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy

JE Wraith, M Scarpa, M Beck, OA Bodamer… - European journal of …, 2008 - Springer
Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is a rare X-linked recessive
disease caused by deficiency of the lysosomal enzyme iduronate-2-sulphatase, leading to …

Immunologic privilege in the central nervous system and the blood–brain barrier

…, JR Ohlfest, A Prat, M Scarpa… - Journal of Cerebral …, 2013 - journals.sagepub.com
The brain is in many ways an immunologically and pharmacologically privileged site. The
blood–brain barrier (BBB) of the cerebrovascular endothelium and its participation in the …

[HTML][HTML] Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management

EA Braunlin, PR Harmatz, M Scarpa… - Journal of inherited …, 2011 - Springer
The mucopolysaccharidoses (MPSs) are inherited lysosomal storage disorders caused by
the absence of functional enzymes that contribute to the degradation of glycosaminoglycans (…

[HTML][HTML] A precision measurement of direct CP violation in the decay of neutral kaons into two pions

…, M Martini, L Masetti, F Petrucci, M Savrie, M Scarpa… - Physics Letters B, 2002 - Elsevier
The direct CP violation parameter Re(ϵ′/ϵ) has been measured from the decay rates of
neutral kaons into two pions using the NA48 detector at the CERN SPS. The 2001 running …

[HTML][HTML] Search for the dark photon in π0 decays

…, A Gianoli, M Martini, F Petrucci, M Savrié, M Scarpa… - Physics Letters B, 2015 - Elsevier
A sample of 1.69 × 10 7 fully reconstructed π 0 → γ e + e − decay candidates collected by the
NA48/2 experiment at CERN in 2003–2004 is analyzed to search for the dark photon ( A ′ …

The beam and detector for the NA48 neutral kaon CP violation experiment at CERN

…, M Porcu, F Rossi, M Savrie, M Scarpa… - Nuclear Instruments and …, 2007 - Elsevier
… 5), the vacuum chamber containing the two beams opened up into a cylindrical tank of
total length 89 m and inner diameter 1.92 m increasing in two steps up to 2.40 m at the end …

Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N …

…, JE Wraith, M Beck, L Arash, M Scarpa… - The Journal of …, 2006 - Elsevier
OBJECTIVE: The objective of this Phase 3 study was to confirm the efficacy and safety of
recombinant human arylsulfatase B (rhASB) treatment of mucopolysaccharidosis type VI (MPS …

Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

…, M Scarpa, C Fiocchi, M Vecchi… - Proceedings of the …, 2010 - National Acad Sciences
IL-33 is a novel member of the IL-1 family and ligand for the IL-1 receptor-related protein,
ST2. Recent evidence suggests that the IL-33/ST2 axis plays a critical role in several …

Influence of different types of grasping on the transport component of prehension movements

M Gentilucci, U Castiello, ML Corradini, M Scarpa… - Neuropsychologia, 1991 - Elsevier
The main aim of the present study was to clarify whether different types of grasping may affect
the transport component of prehension movements. To this purpose two experiments were …

[HTML][HTML] A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency

…, S Nightingale, H Peters, M Scarpa… - … England Journal of …, 2015 - Mass Medical Soc
Background Lysosomal acid lipase is an essential lipid-metabolizing enzyme that breaks
down endocytosed lipid particles and regulates lipid metabolism. We conducted a phase 3 trial …